Mounjaro NHS Availability 2026: Eligibility & Costs | Cured

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro NHS 2026 - UK Price From £124.99

Get Mounjaro at the cheapest UK price from £124.99 plus £20 off your first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off first order using code WEIGHTLOSSNEW

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Your Complete Guide to Mounjaro NHS Availability 2026

Published on: June 03, 2026

Understanding mounjaro NHS availability UK 2026 is essential if you're considering this dual-action weight loss treatment. While Mounjaro (tirzepatide) received MHRA approval for weight management, NHS access remains highly restricted with stringent eligibility criteria and limited availability through specialist services only.

Current Mounjaro NHS Availability Status in 2026

As of 2026, Mounjaro remains available on the NHS only through specialist weight management services, not via standard GP prescription. NICE guidance restricts NHS prescribing to patients meeting specific clinical criteria: a BMI of 35 kg/m² or above with at least one weight-related comorbidity, or a BMI of 30-34.9 kg/m² with three or more weight-related comorbidities [1]. These restrictions mean the majority of UK patients seeking Mounjaro must access it privately.

NHS waiting lists for specialist weight management services currently extend beyond 12-18 months in most Clinical Commissioning Groups. Even after assessment, ongoing supply constraints mean many eligible patients face further delays before treatment can commence. This has driven significant demand for private prescription services where clinical assessment and treatment can begin within days [2].

Who Qualifies for Mounjaro on the NHS?

NHS eligibility criteria for Mounjaro are considerably more restrictive than private prescription pathways. To qualify, you must have completed a structured weight management programme within the past two years, demonstrating commitment to lifestyle modification before pharmacological intervention is considered [1].

Additionally, NHS prescribers must document that you have not achieved adequate weight loss (defined as less than 5% body weight reduction) through diet, exercise, and behavioural interventions alone. Patients with type 2 diabetes may have slightly broader access, but supply limitations mean even eligible patients often cannot access NHS prescriptions in practice.

Medical Exclusions and Contraindications

Both NHS and private prescribers will exclude patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. Pregnancy, breastfeeding, and plans to conceive within the treatment period are absolute contraindications [3]. Your UK prescriber will conduct a thorough medical history assessment regardless of prescription route.

How Mounjaro Works: The Science Behind Tirzepatide

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management. Unlike single-pathway medications, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure [1].

In the SURMOUNT-1 trial, patients receiving the 15mg maintenance dose achieved an average 22.5% body weight reduction over 72 weeks—significantly greater than results seen with semaglutide-based alternatives in comparable populations [1][4]. The dual-receptor mechanism appears to produce superior metabolic benefits, though individual responses vary considerably.

Expected Timeline and Results

Treatment follows a gradual dose escalation protocol starting at 2.5mg weekly, increasing every four weeks to minimise gastrointestinal side effects. Most patients reach the maintenance dose (10mg or 15mg) by week 20. Clinical trials demonstrate that maximum weight loss typically occurs between weeks 60-72, with patients losing an average of 1-2kg per month during the escalation phase [1][4].

Access Route Eligibility Criteria Typical Waiting Time Cost to Patient
NHS Specialist Service BMI ≥35 + comorbidity, completed structured programme 12-18+ months Free (prescription charge may apply)
Private (Cured Pharmacy) BMI ≥27 + weight-related concern 24-48 hours From £124.99
Wegovy (Private) BMI ≥27 + weight-related concern 24-48 hours From £69.00
Saxenda (Private) BMI ≥27 + weight-related concern 24-48 hours From £68.00

Private Prescription Pathway at Cured Pharmacy

At Cured Pharmacy, Mounjaro is available from £124.99 following a free online consultation with a UK-registered prescriber. Our clinical team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), completes assessments within 24 hours, with discreet delivery available across the UK [5].

The private prescription pathway requires completion of a comprehensive medical questionnaire covering your weight history, previous weight loss attempts, current medications, and relevant medical conditions. Our prescribers apply the same clinical safety standards as NHS services but with broader eligibility criteria, enabling treatment for patients with a BMI of 27 kg/m² or above who have weight-related health concerns.

All Mounjaro supplied by Cured Pharmacy is UK-licensed, stored in temperature-controlled pharmaceutical facilities, and dispensed by GPhC-registered pharmacists. Prices are transparent before consultation—no hidden fees or subscription requirements. Patients requiring ongoing treatment receive priority reassessment to ensure continuity of care.

Mounjaro vs Alternative Weight Loss Treatments

While Mounjaro demonstrates superior weight loss outcomes in head-to-head trials, several alternative treatments may suit different patient needs and budgets. Wegovy (semaglutide) produced an average 15% body weight reduction over 68 weeks in the STEP-1 trial—highly effective though somewhat less than tirzepatide's results [2][4].

Saxenda (liraglutide) requires daily injection rather than weekly administration, which some patients find less convenient. Orlistat-based treatments (including prescription-strength Xenical) work through a different mechanism by reducing dietary fat absorption, producing more modest weight loss of 5-10% but at a considerably lower cost point.

Your UK prescriber will discuss which treatment aligns best with your medical history, weight loss goals, injection preference, and budget. Many patients benefit from starting with one medication and transitioning to another if initial results are inadequate or side effects prove problematic.

Combination Approaches and Lifestyle Support

All GLP-1 receptor agonists work most effectively when combined with dietary modification and increased physical activity. Clinical trials demonstrating significant weight loss outcomes included structured lifestyle intervention programmes alongside medication [1][2]. Your prescriber may recommend nutritional guidance, behavioural support, or referral to specialist weight management services to optimise results.

Managing Side Effects and Treatment Expectations

The most common side effects of Mounjaro are gastrointestinal: nausea (reported by 25-30% of patients), diarrhoea, constipation, and reduced appetite. These effects typically peak during dose escalation and diminish as your body adapts to the medication [3]. Eating smaller meals, avoiding high-fat foods, and staying well-hydrated can help minimise discomfort.

Approximately 5-10% of patients discontinue treatment due to persistent gastrointestinal side effects. If you experience severe or prolonged symptoms, contact your prescriber immediately—dose adjustment or temporary treatment pause may be appropriate. Rare but serious side effects include pancreatitis, gallbladder problems, and severe allergic reactions requiring emergency medical attention [3].

Set realistic expectations: while clinical trial averages show substantial weight loss, individual results vary based on baseline weight, adherence to lifestyle modifications, genetic factors, and metabolic health. Your UK prescriber will schedule regular follow-up assessments to monitor progress, adjust dosing if needed, and ensure treatment remains clinically appropriate throughout your weight loss journey.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14881 [accessed 13 August 2026]
  4. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
  5. General Pharmaceutical Council. (2024). Registered Pharmacies. Retrieved from https://www.pharmacyregulation.org/ [accessed 13 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to lifestyle modifications alongside pharmacological treatment.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can you get Mounjaro on the NHS in 2026?
Yes, but only through specialist weight management services with very restrictive eligibility criteria (BMI ≥35 with comorbidity) and waiting times exceeding 12-18 months in most areas. Most UK patients access Mounjaro privately.
What is the BMI requirement for Mounjaro on the NHS?
NHS prescribing requires BMI ≥35 kg/m² with at least one weight-related comorbidity, or BMI 30-34.9 kg/m² with three or more comorbidities, plus completion of a structured weight management programme.
How much does Mounjaro cost privately in the UK?
At Cured Pharmacy, Mounjaro starts from £124.99 per month following a free online consultation with a UK prescriber. Prices are transparent before assessment with no hidden subscription fees.
Do I need a referral to get Mounjaro privately?
No referral is needed for private prescription. Complete a free online consultation at Cured Pharmacy, and a UK-registered prescriber will assess your eligibility within 24 hours.
Is Mounjaro better than Wegovy for weight loss?
Clinical trials show Mounjaro (tirzepatide) produces greater average weight loss than Wegovy (semaglutide)—22.5% vs 15% body weight reduction respectively—though individual responses vary.
How long does it take to see results with Mounjaro?
Most patients notice appetite reduction within the first 2-4 weeks. Significant weight loss typically occurs between weeks 20-72, with maximum effect around 60-72 weeks in clinical trials.
Can I switch from NHS to private prescription for Mounjaro?
Yes. If you're on an NHS waiting list or experiencing supply issues, you can access private prescription immediately. Your treatment history will be considered during the clinical assessment.
What happens if I don't lose weight on Mounjaro?
Your UK prescriber will review your progress at regular intervals. If you achieve less than 5% weight loss after 16 weeks at maintenance dose, treatment discontinuation or alternative options will be discussed.
Will Mounjaro be available on the NHS in 2026?
Mounjaro NHS availability in 2026 is expected to be limited to specialist weight management services only, with strict eligibility criteria. Most patients will continue to need private prescriptions through services like Cured Pharmacy for faster access.
How long is the NHS waiting list for Mounjaro in the UK?
NHS waiting lists for Mounjaro currently exceed 12-18 months in many areas, with availability prioritised for patients with specific medical conditions. Cured Pharmacy offers same-day assessment and next-day delivery, avoiding long NHS waits.
Can I switch from NHS to private Mounjaro prescriptions?
Yes, you can switch from NHS to private prescriptions at any time if you meet clinical eligibility. Cured Pharmacy can continue your treatment at the cheapest UK price from £124.99, ensuring uninterrupted supply.
Is private Mounjaro cheaper than waiting for NHS availability?
Private Mounjaro from Cured Pharmacy starts at £124.99 and provides immediate access, while NHS availability remains limited with long waiting times. Many patients find the cost worthwhile for faster, reliable treatment and weight loss results.
What are the NHS eligibility criteria for Mounjaro in 2026?
NHS Mounjaro availability in 2026 will likely require BMI over 35 with comorbidities or BMI over 40, plus failure of lifestyle interventions. Cured Pharmacy assesses all patients individually with UK-registered prescribers using the same clinical guidelines.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.